#Italy #Milan #West Pharmaceutical #SelfDose #CPHI Worldwide

West Pharmaceutical Showcases Innovative Drug Delivery Solutions

West Pharmaceutical Services, Inc., noted for its cutting-edge injectable drug administration solutions, is set to showcase its expertise at CPHI Worldwide, taking place in Milan, Italy. This year's event will provide West with a platform to highlight how it effectively addresses the challenges within the pharmaceutical packaging and containment sectors.

With over a century of experience, West boasts a solid partnership with prominent pharmaceutical companies worldwide, assisting in overcoming complex drug packaging and delivery challenges. Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer at West, emphasized the company's commitment to advancing patient-centered drug delivery. The focus will be on their innovative SelfDose® patient-controlled injector, which integrates seamlessly with the West Synchrony® S1 prefillable syringe system. This product underscores West's dedication to thoughtful design and enhancing the overall delivery experience for patients.

In addition to showcasing its products, West is set to engage with attendees through technical presentations and panel discussions. One highlighted event is the presentation titled "Strategic CDMO Partnerships in Combination Drug-Device Development: Accelerating Time to Market While Mitigating Risks," scheduled for October 6th, 2026, at the Packaging and Device Innovation Theater. It will be presented by Richard Kieran, Director of Business Development. Another key panel discussion will address the dilemmas associated with large volume drug delivery and patient choice, featuring insights from Dan Yates, Senior Director of Self Injection Systems.

West is more than just a provider of solutions; it is a trusted partner to both established and emerging drug developers. Each year, the company supports customers by ensuring the safe and effective containment and delivery of life-saving and life-enhancing medications. With an impressive workforce of over 10,000 employees spread across 50 locations, including 26 manufacturing sites globally, West has proven its capability to deliver more than 41 billion components and devices annually.

As the fiscal year 2025 concluded, West Pharmaceutical Services reported $3.07 billion in net sales, reinforcing its position as a key player in the pharmaceutical industry. The company is listed on the New York Stock Exchange under the symbol WST and is part of the prestigious Standard & Poor's 500 index.

For additional information on West Pharmaceutical Services and its innovative drug delivery systems, visit their official website or learn more about the CPHI Worldwide event. The insights shared during this year’s conference are expected to pave the way for further advancements in drug packaging and delivery, ultimately benefiting patients globally.

In summary, West Pharmaceutical is not only showcasing its products but also setting the stage for industry-wide discussions about the future of drug delivery and the challenges it faces. Its participation in CPHI Worldwide exemplifies a commitment to leading the industry into a more efficient and patient-centric future.